Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Amazon.com, Inc.
WARNING LETTER
•Amazon.com, Inc.•December 20, 2023

Amazon.com, Inc. – FDA Warning Letter, Dec 20, 2023

Record Details

The FDA issued a Warning Letter to Amazon concerning the distribution of products containing undeclared active pharmaceutical ingredients (APIs) through its website and Fulfillment by Amazon service. Laboratory analyses confirmed that several products, including “MANNERS Energy Boost,” “Round 2,” “WeFun,” “Genergy,” “Big Guys Male Energy Supplement,” and “Mens Maximum Energy Supplement,” marketed as dietary supplements, contained sildenafil or tadalafil. These APIs are active ingredients in FDA-approved erectile dysfunction drugs and were not marketed as supplements or foods before their drug approval, thus excluding them from the dietary supplement definition. Consequently, these products are deemed unapproved new drugs under sections 201(p), 301(d), and 505(a) of the FD&C Act. Furthermore, they are misbranded under sections 502(a), 502(f)(1), and 502(f)(2) of the FD&C Act due to false/misleading labeling, failure to bear adequate directions for use, and lack of adequate warnings, respectively. The undeclared APIs pose serious health risks, particularly interactions with nitrates. Additionally, “X Max Triple Shot Energy Honey,” a food product, was found to contain undeclared tadalafil, constituting a prohibited act under section 301(ll) of the FD&C Act. Amazon is responsible for these violations and must respond within fifteen working days, detailing corrective actions to prevent recurrence and ensure compliance, or face potential legal action, including seizure or injunction.

Company
Amazon.com, Inc.
Inspection date
December 20, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Ann M. Oxenham (Director)
  • Jill P. Furman (Director)
View Company Profile

ID · 5366e2ed-23ff-4fbc-acca-5f94ed68f892

Violation Codes10
21 U.S.C. 353(b)(1)21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 331(d)21 U.S.C. 331(ll)21 U.S.C. 321(ff)21 U.S.C. 321(ff)(3)(B)(i)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.

Other documents for Amazon.com, Inc.
  • WARNING_LETTER - 2025-04-29April 29, 2025
  • WARNING_LETTER - 2025-03-03March 3, 2025
  • WARNING_LETTER - 2024-07-30July 30, 2024
  • WARNING_LETTER - 2023-11-14November 14, 2023
  • WARNING_LETTER - 2023-08-18August 18, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Amazon.com, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.